• Andrew Ramonas
    Lobbying Reporter
  • Beth Frerking
    Editor in Chief
  • David Brown
    Vice President/Editor, ALM
  • Diego Radzinschi
    Photo Editor
  • Jenna Greene
    Senior Reporter
  • Marcia Coyle
    Chief Washington Correspondent
  • Mike Scarcella
    Washington Bureau Chief
  • Todd Ruger
    Capitol Hill Reporter
  • Tony Mauro
    Supreme Court Correspondent
  • Zoe Tillman
    D.C. Courts Reporter

« Senate Confirms Two More Federal Judges | Main | Bank Robber's Lawyer Pitches Supreme Court on Machine Gun Law »

December 20, 2012


RD Legal Funding

This could be the start of some bad occurrences for Eli Lilly. Shareholders are not going to take the actions of bribery very kindly. Especially when it puts in jeopardy profits and the company's well being. This could result in a lawsuit by shareholders against the company.

Mindano Iha

With the widespread corruption on all levels in the pharmaceutical industry it may be deduced that their products cannot be trusted.

The comments to this entry are closed.

Blog powered by Typepad